-
1
-
-
84868337504
-
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease
-
Update. National Institutes of Health/WHO. Available at:, Accessed January 5, 2009
-
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2008 Update. National Institutes of Health/WHO. Available at: http://www.goldcopd.org. Accessed January 5, 2009.
-
(2008)
Global Initiative for Chronic Obstructive Lung Disease (GOLD)
-
-
-
2
-
-
0035446985
-
Inhaled formoterol; dry powder versus ipratropium bromide in chronic obstructive pulmonary disease
-
Dahl R, Greefhorst LAPM, Nowak D, et al. Inhaled formoterol; dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:778-784.
-
(2001)
Am J Respir Crit Care Med
, vol.164
, pp. 778-784
-
-
Dahl, R.1
Greefhorst, L.A.P.M.2
Nowak, D.3
-
3
-
-
0036014549
-
Formoterol in patients with chronic obstructive pulmonary disease: A randomized, controlled, 3-month trial
-
Aalbers R, Ayres J, Backer V, et al. Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial. Eur Respir J. 2002;19:936-943.
-
(2002)
Eur Respir J
, vol.19
, pp. 936-943
-
-
Aalbers, R.1
Ayres, J.2
Backer, V.3
-
4
-
-
37449007559
-
Efficacy and safety of formoterol fumurate delivered by nebulization to COPD patients
-
Gross NJ, Nelson HS, Lapidus RJ, et al. Efficacy and safety of formoterol fumurate delivered by nebulization to COPD patients. Respir Med. 2008;102:189-197.
-
(2008)
Respir Med
, vol.102
, pp. 189-197
-
-
Gross, N.J.1
Nelson, H.S.2
Lapidus, R.J.3
-
5
-
-
36248991849
-
Cardiovascular safety of nebulized formoterol: Results of a placebo-controlled, double-blind phase III study
-
Nelson HS, Gross NJ, Rinehart M, et al. Cardiovascular safety of nebulized formoterol: results of a placebo-controlled, double-blind phase III study. Clin Ther. 2007;29:2167-2178.
-
(2007)
Clin Ther
, vol.29
, pp. 2167-2178
-
-
Nelson, H.S.1
Gross, N.J.2
Rinehart, M.3
-
6
-
-
68749083915
-
Longterm safety of nebulized formoterol: Results of a twelve-month open-label clinical trial
-
Donohue JF, Hanania NA, Fogarty C, et al. Longterm safety of nebulized formoterol: results of a twelve-month open-label clinical trial. Ther Adv Respir Dis. 2008;2:199-208.
-
(2008)
Ther Adv Respir Dis
, vol.2
, pp. 199-208
-
-
Donohue, J.F.1
Hanania, N.A.2
Fogarty, C.3
-
7
-
-
0036181956
-
A longterm evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
-
Casaburi R, Mahler DA, Jones PW, et al. A longterm evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J. 2002;19:217-224.
-
(2002)
Eur Respir J
, vol.19
, pp. 217-224
-
-
Casaburi, R.1
Mahler, D.A.2
Jones, P.W.3
-
8
-
-
34547618224
-
Efficacy and safety of tiotropium in COPD patients in primary care - The SPiRiva Usual CarE (SPRUCE) study
-
Freeman D, Lee A, Price D. Efficacy and safety of tiotropium in COPD patients in primary care - the SPiRiva Usual CarE (SPRUCE) study. Respir Res. 2007;8:45.
-
(2007)
Respir Res
, vol.8
, pp. 45
-
-
Freeman, D.1
Lee, A.2
Price, D.3
-
9
-
-
0141990930
-
Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease
-
Calverley PM, Lee A, Towse L, van Noord J, Witek TJ, Kelsen S. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Thorax. 2003;58: 855-860.
-
(2003)
Thorax
, vol.58
, pp. 855-860
-
-
Calverley, P.M.1
Lee, A.2
Towse, L.3
Van, N.J.4
Witek, T.J.5
Kelsen, S.6
-
10
-
-
53749102775
-
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
-
Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;249:1616-1618.
-
(2008)
N Engl J Med.
, vol.249
, pp. 1616-1618
-
-
Tashkin, D.P.1
Celli, B.2
Senn, S.3
-
11
-
-
33847313718
-
Combination inhaled bronchodilator therapy in the management of chronic obstructive pulmonary disease
-
Nichols J. Combination inhaled bronchodilator therapy in the management of chronic obstructive pulmonary disease. Pharmacotherapy. 2007;27: 447-454.
-
(2007)
Pharmacotherapy
, vol.27
, pp. 447-454
-
-
Nichols, J.1
-
12
-
-
0345414503
-
The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD
-
Cazzola M, Santus P, Di Marco F, et al. The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD. Pulm Pharmacol Ther. 2004;17:35-39.
-
(2004)
Pulm Pharmacol Ther
, vol.17
, pp. 35-39
-
-
Cazzola, M.1
Santus, P.2
Di Marco, F.3
-
13
-
-
23144457098
-
Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD
-
van Noord JA, Aumann J-L, Janssens E, et al. Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. Eur Respir J. 2005;20:214-222.
-
(2005)
Eur Respir J
, vol.20
, pp. 214-222
-
-
Van Noord, J.A.1
Aumann, J.-L.2
Janssens, E.3
-
14
-
-
33645116728
-
Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD
-
van Noord JA, Aumann J-L, Janssens E, et al. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. Chest. 2006;129:509-517.
-
(2006)
Chest
, vol.129
, pp. 509-517
-
-
Van Noord, J.A.1
Aumann, J.-L.2
Janssens, E.3
-
15
-
-
61649115167
-
Formoterol and tiotropium compared with tiotropium alone for treatment of COPD
-
Tashkin DP, Pearle J, Iazzoni D, Varghese ST. Formoterol and tiotropium compared with tiotropium alone for treatment of COPD. COPD. 2009;6:17-25.
-
(2009)
COPD
, vol.6
, pp. 17-25
-
-
Tashkin, D.P.1
Pearle, J.2
Iazzoni, D.3
Varghese, S.T.4
-
16
-
-
33749330419
-
Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease: A pilot study
-
Di Marco F, Verga M, Santus P, et al. Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study. Respir Med. 2006;100:1925-1932.
-
(2006)
Respir Med
, vol.100
, pp. 1925-1932
-
-
Di Marco, F.1
Verga, M.2
Santus, P.3
-
17
-
-
55749112997
-
Formoterol mono- and combination therapy with tiotropium in patients with COPD: A 6-month study
-
Vogelmeier C, Kardos P, Harari S, et al. Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study. Respir Med. 2008;102:1511-1520.
-
(2008)
Respir Med
, vol.102
, pp. 1511-1520
-
-
Vogelmeier, C.1
Kardos, P.2
Harari, S.3
-
18
-
-
40249111478
-
Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: A placebo-controlled trial
-
Tashkin DP, Littner M, Andrews CP, et al. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial. Respir Med. 2008;102:479-487.
-
(2008)
Respir Med
, vol.102
, pp. 479-487
-
-
Tashkin, D.P.1
Littner, M.2
Andrews, C.P.3
-
19
-
-
67649317017
-
Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide
-
Hanania NA, Boota A, Kerwin E, et al. Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide. Drugs. 2009;69:1205-1216.
-
(2009)
Drugs
, vol.69
, pp. 1205-1216
-
-
Hanania, N.A.1
Boota, A.2
Kerwin, E.3
-
20
-
-
0026871146
-
A selfcomplete measure for chronic airflow limitation - The St. George's Respiratory Questionnaire
-
Jones PW, Quirk FJ, Baveystock CM, et al. A selfcomplete measure for chronic airflow limitation - the St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992;145:1321-1327.
-
(1992)
Am Rev Respir Dis
, vol.145
, pp. 1321-1327
-
-
Jones, P.W.1
Quirk, F.J.2
Baveystock, C.M.3
-
21
-
-
20144378063
-
Development of self-administered versions of modified baseline and transition dyspnea indexes in COPD
-
Mahler DA, Ward J, Ferrio-Carrion G, et al. Development of self-administered versions of modified baseline and transition dyspnea indexes in COPD. COPD. 2004;1:165-172.
-
(2004)
COPD
, vol.1
, pp. 165-172
-
-
Mahler, D.A.1
Ward, J.2
Ferrio-Carrion, G.3
-
22
-
-
0021256105
-
The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes
-
Mahler DA, Weinberg CH, Wells CK, et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984;85:751-758.
-
(1984)
Chest
, vol.85
, pp. 751-758
-
-
Mahler, D.A.1
Weinberg, C.H.2
Wells, C.K.3
-
23
-
-
20144362569
-
St. George's Respiratory Questionnaire: MCID
-
Jones PW. St. George's Respiratory Questionnaire: MCID. COPD. 2005;2:75-79.
-
(2005)
COPD
, vol.2
, pp. 75-79
-
-
Jones, P.W.1
-
24
-
-
20144382361
-
Minimal clinically important differences in COPD lung function
-
Donohue JF. Minimal clinically important differences in COPD lung function. COPD. 2005;2: 111-124.
-
(2005)
COPD
, vol.2
, pp. 111-124
-
-
Donohue, J.F.1
-
25
-
-
33646042213
-
Dyspnoea with activities of daily living versus peak dyspnoea during exercise in male patients with COPD
-
Oga T, Nishimura K, Mitsuhiro T, et al. Dyspnoea with activities of daily living versus peak dyspnoea during exercise in male patients with COPD. Respir Med. 2006;100:965-971.
-
(2006)
Respir Med
, vol.100
, pp. 965-971
-
-
Oga, T.1
Nishimura, K.2
Mitsuhiro, T.3
-
26
-
-
0037322464
-
Minimal important difference of the transition dyspnoea index in a multinational clinical trial
-
Witek TJ Jr, Mahler DA. Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J. 2003;21:267-272.
-
(2003)
Eur Respir J
, vol.21
, pp. 267-272
-
-
Witek Jr., T.J.1
Mahler, D.A.2
-
27
-
-
55649089631
-
Rational timing of combination therapy with tiotropium and formoterol in moderate and severe COPD
-
Terzano C, Petroianni A, Conti V, et al. Rational timing of combination therapy with tiotropium and formoterol in moderate and severe COPD. Respir Med. 2008;102:1701-1707.
-
(2008)
Respir Med
, vol.102
, pp. 1701-1707
-
-
Terzano, C.1
Petroianni, A.2
Conti, V.3
-
28
-
-
60949104107
-
Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD
-
Tashkin DP, Donohue JF, Mahler DA, et al. Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD. Respir Med. 2009;103:516-524.
-
(2009)
Respir Med
, vol.103
, pp. 516-524
-
-
Tashkin, D.P.1
Donohue, J.F.2
Mahler, D.A.3
-
29
-
-
49449094831
-
Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD
-
Rabe KF, Timmer W, Sagkriotis A, et al. Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD. Chest. 2008;34:255-262.
-
(2008)
Chest
, vol.34
, pp. 255-262
-
-
Rabe, K.F.1
Timmer, W.2
Sagkriotis, A.3
-
30
-
-
51049107684
-
Nebulized formoterol fumarate: Dose selection and pharmacokinetics
-
Gross NJ, Kerwin E, Levine B, et al. Nebulized formoterol fumarate: Dose selection and pharmacokinetics. Pulm Pharmacol Ther. 2008;21:818-823.
-
(2008)
Pulm Pharmacol Ther
, vol.21
, pp. 818-823
-
-
Gross, N.J.1
Kerwin, E.2
Levine, B.3
-
31
-
-
13544253826
-
Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology
-
Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest. 2005;127:335-371.
-
(2005)
Chest
, vol.127
, pp. 335-371
-
-
Dolovich, M.B.1
Ahrens, R.C.2
Hess, D.R.3
-
32
-
-
34247186876
-
Comparing COPD treatment: Nebulizer, metered dose inhaler, and concomitant therapy
-
Tashkin DP, Klein GL, Colman SS, et al. Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy. Amer J Med. 2007;120:435-441.
-
(2007)
Amer J Med
, vol.120
, pp. 435-441
-
-
Tashkin, D.P.1
Klein, G.L.2
Colman, S.S.3
-
33
-
-
67649380868
-
Nebulized formoterol effect on bronchodilation and satisfaction in COPD patients compared to QID ipratropium/albuterol MDI
-
Sutherland ER, Brazinsky S, Feldman G, et al. Nebulized formoterol effect on bronchodilation and satisfaction in COPD patients compared to QID ipratropium/albuterol MDI. Curr Med Res Opin. 2009;25:653-661.
-
(2009)
Curr Med Res Opin
, vol.25
, pp. 653-661
-
-
Sutherland, E.R.1
Brazinsky, S.2
Feldman, G.3
-
34
-
-
0036591408
-
Survey of patients' views of domiciliary nebulizer treatment for chronic lung disease
-
Barta SK, Crawford A, Roberts CM. Survey of patients' views of domiciliary nebulizer treatment for chronic lung disease. Respir Med. 2002;96: 375-381.
-
(2002)
Respir Med
, vol.96
, pp. 375-381
-
-
Barta, S.K.1
Crawford, A.2
Roberts, C.M.3
|